The Gerhard Zbinden memorial lecture: Are environmental chemicals affecting the integrity or expression of the human genome?

Toxicology Letters

Volumn 112-113, Issue , 2000, Pages 3-8

  Ashby, John ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Carcinogen; Chemicals; Endocrine disruption; Estrogen; Human genome; Phytoestrogen; Transgenic mouse

Indexed keywords

ENVIRONMENTAL CHEMICAL; ESTROGEN; PHYTOESTROGEN;

ANIMAL MODEL; BIOASSAY; CARCINOGEN TESTING; CONFERENCE PAPER; ENDOCRINE DISEASE; ENVIRONMENTAL EXPOSURE; ESTROGEN ACTIVITY; GENE DISRUPTION; GENE EXPRESSION; HUMAN; HUMAN GENETICS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSGENIC ANIMAL;

ANIMALS; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION; GENOME, HUMAN; HUMANS; RECEPTORS, ESTROGEN; RESEARCH DESIGN; STRUCTURE-ACTIVITY RELATIONSHIP; TOXICOLOGY;

MAMMALIA; MUS MUSCULUS; RODENTIA;

EID: 0034653380     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00244-1     Document Type: Conference Paper

References (19)

1. Ashby J. Identifying potential human carcinogens-the role of genetically altered rodents. Toxicol. Path. 25:1997;241-243.
2. Ashby J. Dose levels of 0.02-0.2 μg/kg/day DES is not suitable for use as a positive control in endocrine toxicity studies. Editorial Reg. Toxicol. Pharm. 29:1999;235-237.
3. Ashby J., Elliott B.M. Editorial: Reproducibility of endocrine disruption data. Reg. Toxicol. Pharmacol. 26:1997;94-95.
4. Ashby J., Tinwell H. Estrogenic activity of Burgen bread to the female rat. Hum. Exp. Toxicol. 17:1998;598-599.
5. Ashby J., Tinwell H., Haseman J. Lack of effects for low dose levels of bisphenol A (BPA) and diethylstilbestrol (DES) on the prostate gland of CF1 mice exposed in utero. Reg. Toxicol. Pharmacol. 30:1999;156-166.
6. Ashby J., Tinwell H., Pennie W., Brooks A.N., Lefevre P.A., Beresford N., Sumpter J. Partial and weak estrogenicity of the red wine constituent resveratrol. J. Appl. Toxicol. 19:1999b;39-45.
7. Ashby J., Tinwell H., Soames A.R., Foster J.R. Uterotrophic activity of coumestrol in the immature rat associated with increased uterine hyperplasia and DNA content. Environ. Health. Perspect. 107:1999;819-822.
8. Brzozowski A.M., Pike A.C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.-A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
9. Cagen S.Z., Waechter J.M. Jr, Dimond S.S., Breslin W.J., Butala J.H., Jekat F.W., Joiner R.L., Shiotsuka R.N., Veenstra G.E., Harris L.R. Normal reproductive organ development in CF-1 mice following prenatal exposure to Bisphenol A. Toxicol. Sci. 50:1999;36-44.
10. Massaad C., Barouki R. An assay for the detection of xenoestrogens based on a promoter containing overlapping EREs. Environ. Health Perspect. 107:1999;563-566.
11. Monosson E., Kelce W.R., Lambright C., Ostby J., Gray L.E. Jr Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicol. Ind. Health. 15:1999;65-79.
12. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ. Health Perspect. 105:1997;70-76.
13. Odum J., Lefevre P.A., Tittensor S., Paton D., Harris C.A., Beresford N.A., Sumpter J.P., Ashby J. The rodent uterotrophic assay: Critical protocol features, studies with nonylphenol and comparison with a yeast estrogenicity assay. Reg. Toxicol. Pharmacol. 25:1997;176-188.
14. Odum J., Pyrah I.T.G., Foster J.R., Van Miller J.P., Joiner R.L., Ashby J. Comparative activities of p-nonylphenol and diethylstilbestrol in Noble rat mammary gland and uterotrophic assays. Reg. Toxicol. Pharmacol. 29:1999;105-184.
15. Ostby J., Kelce W.R., Lambright C., Wolf C.J., Mann P., Gray L.E. Jr The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol. Ind. Health. 15:1999;80-93.
16. Pennie W.D., Aldridge T.A., Brooks A.N. Differential activation by xenoestrogens of ERa and ERb when linked to different response elements. J. Endocrinol. 158:1998;R11-R14.
17. Robinson D. The ILSI role in the evaluation of alternative methodologies for the assessment of carcinogenic risk. Toxicol. Path. 26:1998;474-475.
18. Routledge E.J., Sumpter J.P. Estrogenic activity of surfactants and their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem. 15:1996;241-248.
19. Tennant R.W., French J.E., Spalding J.W. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103:1995;942-950.